Trinity Biotech (TRIB) Short-term Investments (2017 - 2025)

Trinity Biotech (TRIB) has reported Short-term Investments for 6 consecutive years, with $2.8 million the latest figure, recorded in Q2 2025.

• Quarterly Short-term Investments changed N/A year-over-year to $2.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.8 million (changed N/A YoY) and the FY2024 annual result came in at $2.5 million, up 1127.5% from the prior year.
• Short-term Investments climbed to $2.8 million in Q2 2025 per TRIB's latest filing, from $2.5 million in the prior quarter.
• Over the last five years, Short-term Investments for TRIB reached as high as $2.8 million in Q2 2025 and fell as low as $100000.0 in Q4 2022.
• A 4-year average of $1.4 million and a median of $1.3 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2023 — Short-term Investments soared 100.0% — and 2024, when it surged 1127.5%.
• Year by year, Short-term Investments stood at $100000.0 in 2022, then surged by 100.0% to $200000.0 in 2023, then jumped by 1127.5% to $2.5 million in 2024, then gained by 12.55% to $2.8 million in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $2.8 million, $2.5 million, and $200000.0 for Q2 2025, Q4 2024, and Q4 2023 respectively.